Here are the numbers...
CAMBRIDGE NEUROSCIENCE, INC.
Condensed Consolidated Statements of Operations
(unaudited)
(in thousands, except per share data)
Three Months Ended Six Months Ended
June 30, June 30,
1997 1996 1997 1996
Revenues
Research and
development $1,100 $676 $2,194 $1,746
Operating expenses
Research and
development 5,008 3,290 9,547 6,366
General and
administrative 654 592 1,388 1,240
Total expenses 5,662 3,882 10,935 7,606
Loss from operations (4,562) (3,206) (8,741) (5,860)
Interest income 655 257 1,184 540
Net loss $(3,907) $(2,949) $(7,557) $(5,320)
Net loss per
common share $(0.22) $(0.22) $(0.44) $(0.39)
Weighted average
shares outstanding 17,789 13,562 17,206 13,554
Condensed Consolidated Balance Sheets
(in thousands)
June 30, December 31,
1997 1996
(unaudited)
Cash and cash equivalents $34,332 $26,664
Marketable securities 11,575 ---
Prepaid expenses and other current assets 1,394 1,271
Equipment, furniture and fixtures, net 936 1,285
Total assets $48,237 $29,220
Current liabilities $7,790 $9,573
Stockholders' equity 40,447 19,647
Total liabilities and stockholders' equity $48,237 $29,220 |
